Effect of Superior Laryngeal Nerve Blocks on Patient Outcomes in Laryngeal Surgery
Effect of Intraoperative Superior Laryngeal Nerve Blocks on Patient Outcomes in Microdirect Laryngoscopy for Benign Vocal Fold Lesions: A Randomized Trial
Rutgers, The State University of New Jersey
28 participants
Jul 11, 2025
INTERVENTIONAL
Conditions
Summary
Patients undergoing surgery on their vocal cord will either receive a numbing injection to their throat or a saline injection during surgery. Symptoms such as how much coughing or pain patients have after surgery, as well as whether patient's voice gets better will be interrogated.
Eligibility
Inclusion Criteria6
- Patient is aged 18 years or older at time of consent
- Patient has suspected or confirmed benign vocal fold lesion
- Patient is planning to undergo direct laryngoscopy with excision of the vocal fold lesion
- Patient is English or Spanish speaking
- Patient is not pregnant per self report
- Patient is not incarcerated
Exclusion Criteria7
- Patient is not 18 years of age or older at consent date
- Patient does not speak English or Spanish
- Patient is currently pregnant or plans to become pregnant prior to their study procedure
- Patient has a laryngeal malignancy or found to find a laryngeal malignancy on final pathology
- Patient will not be undergoing direct laryngoscopy with excision of lesion
- Patient is unable to provide consent or complete study activities
- Patient is incarcerated
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will receive a superior laryngeal nerve block consisting of 1 ml of 0.25% bupivacaine and 1mL of triamcinolone acetate 40 mg/ml to the neck on the side of the vocal cord lesion during their surgery.
Patients will receive a saline placebo of 2mL saline to the neck on the side of the vocal cord lesion during their surgery.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06734975